Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Healthcare Biotechnology
Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab... see more

Recent & Breaking News (TSX:MBX)

Microbix Honours the Passing of its Founder

GlobeNewswire September 13, 2023

Microbix Reports Results for Q3 Fiscal 2023

GlobeNewswire August 10, 2023

Microbix Successfully Upgrades Logistics Software Systems Achieves "Go-Live" with New ERP and eQMS Solutions

GlobeNewswire August 4, 2023

Microbix Presents Results of STI Test Controls at AACC

GlobeNewswire July 24, 2023

Microbix QAPs Supporting HPV Testing Across The Netherlands

GlobeNewswire July 5, 2023

Microbix & Labquality Create Novel Testing Accreditation Program

GlobeNewswire June 20, 2023

Microbix Presents Results of STI Test Controls at ASM Microbe

GlobeNewswire June 13, 2023

Microbix Announces Extension of Warrant Expiry Date

GlobeNewswire May 18, 2023

Microbix Secures Funded Drug Commercialization Agreement

GlobeNewswire May 16, 2023

Microbix Reports Results for Q2 Fiscal 2023

GlobeNewswire May 11, 2023

Microbix Presenting at the 2023 Bloom Burton Conference

GlobeNewswire April 20, 2023

Microbix Announces Annual and Special Meeting Voting Results

GlobeNewswire March 30, 2023

Microbix (TSX:MBX) receives government investments

Trevor Abes  March 20, 2023

Governments of Ontario and Canada Invest in Microbix

GlobeNewswire March 20, 2023

Microbix Supporting Australian Point-of-Care Testing Program

GlobeNewswire March 1, 2023

Microbix Announces Issuance of Stock Options

GlobeNewswire February 27, 2023

Microbix Biosystems (TSX:MBX) records Q1 sales of $2.5M, net loss of $1.3M

Caroline Egan  February 9, 2023

Microbix Reports Results for Q1 Fiscal 2023 Sales of $2.5 million, Net Loss of $1.3 million

GlobeNewswire February 9, 2023

Microbix Presenting Results of Collaboration with Health PEI

GlobeNewswire February 6, 2023

Microbix Launches QAP to Support "Monkeypox" Testing

GlobeNewswire January 30, 2023